Life Science companies that stand to thrive in the increasingly evidence-based marketplace will be those who embrace value-based healthcare and catalyze the system movement toward enhanced outcomes. By understanding the interdependent trends, firms can drive improvements in population health outcomes while navigating these transformational changes.